Posts by: Margarida Azevedo

Margarida Azevedo

Margarida graduated with a BS in Health Sciences from the University of Lisbon and a MSc in Biotechnology from Instituto Superior Técnico (IST-UL). She worked as a molecular biologist research associate at a Cambridge UK-based biotech company that discovers and develops therapeutic, fully human monoclonal antibodies.

March 30, 2020March 30, 2020

Common Antibody Abnormalities in Gaucher Not Linked to Disease Severity, Study Finds

News

Although common in patients with Gaucher disease, antibody abnormalities are not associated with disease severity, a large French study reports. Still, monitoring these patients is important because they may develop ... Read more

July 27, 2016

Gaucher Disease Case: Ankle Pain in Young Woman

News

One of the most disabling aspects of Gaucher disease (GD) is skeletal issues that leave patients often experiencing bone pain and impaired mobility. In a recent case report, researchers described a young woman with ... Read more

July 19, 2016

Gaucher Disease Drug Analysis Shows Cerdelga Is Comparable to Cerezyme, Researchers Say

News

Cerdelga (eliglustat) was recently approved in the U.S. and Europe for the long-term treatment of a subset of adult patients with Gaucher disease type 1 (GD1). Researchers at Sanofi Genzyme analyzed ... Read more

July 7, 2016July 7, 2016

Rare Case of Gaucher Patient with Eye Lesions Despite Enzyme Replacement Therapy Reported

News

Researchers described the case of a patient with Gaucher Disease type 3 (GD3), who developed eye lesions despite long-term enzyme replacement therapy (ERT). In light of such findings, they recommend that thorough ophthalmic ... Read more

June 30, 2016June 30, 2016

Gaucher Disease Study from Argentina Identifies Markers for Early Parkinson’s Disease Detection

News

Researchers analyzed the occurrence of Parkinson’s disease (PD) markers in type 1 Gaucher disease (GD) patients, who generally have an increased risk of developing Parkinson’s, and identified a series of markers ... Read more

June 23, 2016June 23, 2016

People with Gaucher Disease Type 1 Often Taking Drugs for Range of Illnesses, Study Finds

News

Researchers investigated the range of associated conditions in patients with Gaucher disease type 1, the drugs prescribed to treat them, and their potential for drug-drug interactions with GD specific therapies using ... Read more

June 8, 2016

Gaucher Disease Literature Review Assesses Fatigue Burden, Assessment, Unmet Needs

News

Researchers at Israel’s Rambam Health Care Campus and Pfizer conducted a literature review with the objective of providing insight into the measurement, management, and practice guidelines of fatigue in Gaucher ... Read more

June 7, 2016

Researchers Link GBA Gene Variants in Sweden to Parkinson’s Disease

News

A multi-disciplinary team of researchers from several Swedish institutions evaluated the involvement of mutations in glucocerebrosidase (GBA), in the development of Gaucher disease in relationship to Parkinson’s Disease cases. Three genetic ... Read more